Mkts

Crinetics Pharmaceuticals, Inc.

NASDAQ: CRNX
$0.00+0.11 (+0.13%)
As of Dec 31, 7:00 PM ET

Key statistics

52-week range
32.3085.01
Today
Open0.00
Previous close0.00
Volume—
Valuation
Market cap9.01B
P/E ratio—
EPS (TTM)-5.05
Income & risk
Dividend / yield—
Beta-0.02
Avg volume3.26M
Discussion

CRNX News

Stories mentioning CRNX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue10,7346,161143.001,031361.000.000.00399.00
Cost of Goods Sold200.000.00
Gross Profit10,534361.00
Operating Expenses
Research & Development100,08185,05390,46480,30176,24066,56661,90558,344
Sales General & Admin49,84235,52624,838
Total Operating Expenses142,729130,143111,76694,74587,79783,182
Operating Income (Loss)(140,378)(133,666)(142,586)(129,112)(111,405)(94,745)(87,797)(82,783)
Interest Income12,66411,15612,54413,45514,83414,36811,0068,741
Interest Expense
Other Expense(131.00)(49.00)(203.00)(37.00)
Pretax Income
Tax Provision
Net Income (Loss)(127,845)(122,815)(130,091)(115,637)(96,774)(80,595)(76,828)(74,055)
Earnings Per Share (Basic)(1.23)(1.31)(1.38)(1.23)(1.04)(1.00)(0.96)(0.94)
Earnings Per Share (Diluted)(1.23)(1.31)(1.38)(1.23)(1.04)(1.00)(0.96)(0.94)
Weighted Average Shares Outstanding (Basic)104,09994,05794,21593,79193,10280,78380,09179,008
Weighted Average Shares Outstanding (Diluted)104,09994,05794,21593,79193,10280,78380,09179,008

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CRNX

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRNX. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET), up 0.1% on the day. That gives Crinetics Pharmaceuticals a market capitalisation of $9.0B.

Over the past 52 weeks CRNX has traded between $32.30 and $85.01.

Revenue for the quarter ended Mar 31, 2026 was $10.7M; a net loss of $127.8M. Revenue was up 2873% from $361.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$10.7M-$127.8M-1191.0%
Dec 31, 2025$6.2M-$122.8M-1993.4%
Sep 30, 2025$143.0K-$130.1M-90972.7%
Jun 30, 2025$1.0M-$115.6M-11216.0%

From Crinetics Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…